Savara (SVRA) CFO exercises stock options and ends with 536,032 shares
Rhea-AI Filing Summary
Savara Inc Chief Financial Officer David L. Lowrance exercised several stock option grants on March 18, 2026, acquiring a total of 366,747 shares of Common Stock through option exercises at strike prices ranging from $1.11 to $4.45 per share. To cover exercise costs and tax obligations, 116,760 shares of Common Stock were withheld by the issuer in transactions coded as F, which are tax-withholding dispositions rather than open‑market sales. Following these transactions, Lowrance directly owned 536,032 shares of Savara common stock. The derivative transactions reflect routine option exercises tied to grants that vest in quarterly installments, as described in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 249,987 shares
Net Buy
18 txns
Insider
Lowrance David L
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 80,684 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 75,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 130,650 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 43,063 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 24,850 | $0.00 | $0.00 |
| Exercise | Common Stock | 80,684 | $1.51 | $122K |
| Exercise Price or Tax Liability | Common Stock | 24,174 | $5.04 | $122K |
| Exercise | Common Stock | 75,000 | $1.59 | $119K |
| Exercise Price or Tax Liability | Common Stock | 23,661 | $5.04 | $119K |
| Exercise | Common Stock | 130,650 | $1.23 | $161K |
| Exercise Price or Tax Liability | Common Stock | 31,885 | $5.04 | $161K |
| Exercise | Common Stock | 43,063 | $1.11 | $48K |
| Exercise Price or Tax Liability | Common Stock | 9,485 | $5.04 | $48K |
| Exercise | Common Stock | 12,500 | $4.45 | $56K |
| Exercise Price or Tax Liability | Common Stock | 11,037 | $5.04 | $56K |
| Exercise | Common Stock | 24,850 | $3.35 | $83K |
| Exercise Price or Tax Liability | Common Stock | 16,518 | $5.04 | $83K |
Holdings After Transaction:
Stock Option (Right to Buy) — 563,937 shares (Direct);
Common Stock — 536,032 shares (Direct)
Footnotes (6)
- F1. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of November 1, 2016, subject to the reporting person's continued service with the Issuer.
- F2. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.
- F3. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer.
- F4. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer.
- F5. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer.
- F6. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Savara (SVRA) report for CFO David L. Lowrance?
Savara reported that CFO David L. Lowrance exercised multiple stock options, acquiring 366,747 shares of Common Stock on March 18, 2026. The filing also shows tax-withholding dispositions where shares were delivered to cover exercise costs and related tax liabilities.
Were any of the Savara (SVRA) CFO’s Form 4 transactions open-market stock sales?
No open‑market sales are shown. The only dispositions reported are transactions coded F, which represent shares withheld by the issuer to pay the option exercise price or related tax liabilities. These are administrative, tax-related events rather than discretionary market sales.
What stock option grants did Savara (SVRA) CFO exercise in this Form 4?
The CFO exercised options to acquire shares at strike prices of $1.11, $1.23, $1.51, $1.59, $3.35 and $4.45. These options relate to grants that vest in sixteen equal quarterly installments, subject to continued service.
What do the vesting footnotes in the Savara (SVRA) Form 4 indicate about the CFO’s options?
The footnotes state each option grant vests in sixteen equal quarterly installments starting from specific grant dates, such as November 1, 2016 and December 12, 2024. Vesting is conditioned on the CFO’s continued service with Savara, reflecting typical long-term equity compensation.